SOPHARMA AD (5/2023) Received corrected tender offer addressed to the shareholders of “Sopharma” AD from “Donev Investments Holding” AD

Podstawa prawna: art. 56. 1. 2 of Act on Public Offering. Sofia, Bulgaria, January 13, 2023 – According to the requirements of art. 100t of LPOS, the Board of Directors of “Sopharma” AD (SFA: “BFB – Sofia”, SPH: Warsaw Stock Exchange) announces that on January 13, 2023, “Sopharma” AD received a corrected tender offer, registered with the Financial Supervision Commission …

Czytaj dalej

SOPHARMA AD (3/2023) Sales revenues for December 2022

Podstawa prawna: art. 56. 1. 2 of Act on Public Offering. “Sopharma” AD (the Company) notifies that for December 2022 the Company recorded an increase in sales of 19% compared to the same month of the previous year, incl. 14% increase in domestic sales and 21% increase in export sales. Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1 kom espi zdz Pochodzenie informacji: pap-mediaroom.pl

Czytaj dalej